Show simple item record

Cardiotoxicity of anticancer therapies. Towards the implementation of cardio-oncology units Cardiotoxicidad inducida por tratamientos oncológicos. Fundamentos para la implementación de equipos de Cardio-Oncología

Authordc.contributor.authorHameau, Rene 
Authordc.contributor.authorGabrielli, Luigi 
Authordc.contributor.authorGarrido, Marcelo 
Authordc.contributor.authorGuzmán, Ana María 
Authordc.contributor.authorRetamal, Ignacio 
Authordc.contributor.authorVacarezza, María José 
Authordc.contributor.authorGreig, Douglas 
Authordc.contributor.authorOcqueteau, Mauricio 
Authordc.contributor.authorSánchez, César 
Authordc.contributor.authorPizarro, Marcela 
Authordc.contributor.authorCorvalán, Alejandro 
Authordc.contributor.authorLavandero González, Sergio 
Authordc.contributor.authorCastro, Pablo F. 
Authordc.contributor.authorMartínez, Gonzalo 
Admission datedc.date.accessioned2019-03-18T12:02:14Z
Available datedc.date.available2019-03-18T12:02:14Z
Publication datedc.date.issued2018
Cita de ítemdc.identifier.citationRevista Medica de Chile, Volumen 146, Issue 1, 2018, Pages 68-77
Identifierdc.identifier.issn07176163
Identifierdc.identifier.issn00349887
Identifierdc.identifier.other10.4067/s0034-98872018000100068
Identifierdc.identifier.urihttp://repositorio.uchile.cl/handle/2250/167459
Abstractdc.description.abstract© 2018, Sociedad Medica de Santiago. All rights reserved. Recently, we have witnessed major improvements in cancer treatment. Early diagnosis and development of new therapies have reduced cancer-related mortality. However, these new therapies, along with greater patient survival, are associated with an increase in untoward effects, particularly in the cardiovascular system. Although cardiotoxicity induced by oncologic treatments affects predominantly the myocardium, it can also involve other structures of the cardiovascular system, becoming one of the main causes of morbidity and mortality in those who survive cancer. The main objective of cardio-oncology is to achieve the maximum benefits of oncologic treatments while minimizing their deleterious cardiovascular effects. It harbors the stratification of patients at risk of cardiotoxicity, the implementation of diagnostic tools (imaging techniques and biomarkers) for early diagnosis, preventive strategies and early treatment options for
Lenguagedc.language.isoen
Publisherdc.publisherSociedad Medica de Santiago
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
Sourcedc.sourceRevista Medica de Chile
Keywordsdc.subjectCancer
Keywordsdc.subjectCardiotoxicity
Keywordsdc.subjectDrug therapy
Keywordsdc.subjectHeart failure
Keywordsdc.subjectRadiotherapy
Títulodc.titleCardiotoxicity of anticancer therapies. Towards the implementation of cardio-oncology units Cardiotoxicidad inducida por tratamientos oncológicos. Fundamentos para la implementación de equipos de Cardio-Oncología
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadorSCOPUS
Indexationuchile.indexArtículo de publicación SCOPUS
uchile.cosechauchile.cosechaSI


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile